Status:

COMPLETED

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Lead Sponsor:

Keya Medical

Collaborating Sponsors:

Medical University of South Carolina

Conditions:

Coronary Artery Disease

Myocardial Ischemia

Eligibility:

All Genders

18+ years

Brief Summary

DEEPVESSEL FFR is a medical device that is designed to extract three- dimensional coronary tree structures and generate computed tomography-derived fraction flow reserve (FFR) values from coronary CT ...

Detailed Description

Coronary artery disease (CAD) is the most common type of heart disease, and it is the leading cause of death worldwide in both men and women. CAD happens when the coronary arteries become hardened and...

Eligibility Criteria

Inclusion

  • Patients' age ≥18 years;
  • Has coronary CTA images acquired by ≥64 multidetector row CT scanner, no earlier than 2016 and within 60 days of the ICA-FFR procedure;
  • Coronary CTA image shows at least one vessel segment (≥2mm diameter) with a diameter stenosis of 30%-90%;

Exclusion

  • Patients with any of the following conditions at the time of CTA imaging:
  • Acute myocardial infarction;
  • Unstable angina;
  • Pulmonary edema;
  • Heart function classification level III and IV (NYHA heart function classification);
  • Implantable cardioverter defibrillator (ICD);
  • Prior percutaneous coronary intervention (PCI) or pacemaker surgery;
  • Prior coronary artery bypass grafting (CABG) surgery;
  • Prior heart valve replacement;
  • Prior history of complex congenital heart disease;
  • Prior history of cardiomyopathy;
  • BMI \>35;
  • Coronary total occlusion.

Key Trial Info

Start Date :

August 10 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

302 Patients enrolled

Trial Details

Trial ID

NCT04828590

Start Date

August 10 2020

End Date

December 31 2021

Last Update

April 22 2022

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Holy Cross Health

Fort Lauderdale, Florida, United States, 33308

2

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

3

Oregon Health & Science University

Portland, Oregon, United States, 97239

4

Medical University of South Carolina

Charleston, South Carolina, United States, 29407